Penpulimab injection: Clinical Trials

9 trials of Penpulimab injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 recruiting, 2 terminated, 1 active not recruiting. 6 Phase 2, 5 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Recruiting 2, Unknown 2, Active not recruiting 1, Completed 1
Phase 15Terminated 2, Unknown 2, Recruiting 1
Phase 31Completed 1

Follow Penpulimab injection: new trials by email Literature Review of Penpulimab injection trials Research Report on Penpulimab injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
LM-108 injection, Penpulimab injection, Paclitaxel for injection (albumin bound) - Advanced Pancreatic Cancer
Phase 1 / Phase 2RecruitingChia Tai Tianqing Pharmaceutical Group Co., Ltd.722025-04-112026-03-10
Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma.
TQB2223 injection, Penpulimab Injection - Advanced Hepatocellular Carcinoma
Phase 1TerminatedChia Tai Tianqing Pharmaceutical Group Co., Ltd.222024-05-302025-11-21
A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.
TQB2618 injection, Penpulimab injection, Anlotinib hydrochloride capsules - Colorectal Cancer
Phase 1UnknownChia Tai Tianqing Pharmaceutical Group Co., Ltd.752024-01-132024-01-23
Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC
Penpulimab injection, cisplatin, albumin-paclitaxel - Head and Neck Squamous Cell Carcinoma
Phase 2Active not recruitingShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University722023-10-172026-09-30
A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC).
Penpulimab injection, TQB2618 injection, Anlotinib Hydrochloride Capsules - Advanced Hepatocellular Carcinoma
Phase 1TerminatedChia Tai Tianqing Pharmaceutical Group Co., Ltd.292023-08-152025-08-12
To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory Lymphoma
TQB2618 injection, Penpulimab injection - Relapsed/Refractory Lymphoma
Phase 1 / Phase 2UnknownChia Tai Tianqing Pharmaceutical Group Co., Ltd.922022-06-092023-02-14
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
Anlotinib hydrochloride capsule, Penpulimab Injection, XELOX - Carcinoma, Gastrointestinal Diseases
Phase 2RecruitingThe First Affiliated Hospital with Nanjing Medical University802022-03-162023-11-07
Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
Anlotinib, AK105, Radiotherapy - MGMT-Unmethylated Glioblastoma
Phase 2UnknownThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School282021-09-012021-09-05
Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors
Inosine 0.2g orally 3 times/day, PD-1/PD-L1 inhibitor ,chemotherapy/targeting - Advanced Solid Tumor
Phase 2 / Phase 3CompletedBeijing Friendship Hospital1722019-05-012023-04-12

Conditions studied

Carcinoma (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Lymphoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Stomach Neoplasms (1)

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (5)  ·  Beijing Friendship Hospital (1)  ·  Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1)  ·  The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)  ·  The First Affiliated Hospital with Nanjing Medical University (1)

Countries

China (9)

Results publications

PMID 38022553, PMID 39267574, PMID 41963080